Trade Mark Journal No.2025/045 7 November 2025
WO0000001882134 (5,10,20,35,44)
Office of origin: Israel
Date of International Registration:26 May 2025
Date of designation in the UK:
26 May 2025
International priority date claimed: 6 May 2025
(Israel)
(383423)
- Class 5
- Medicinal preparations used as a narcotic antagonist; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations.
- Class 10
- Medical kits consisting of intranasal drug delivery devices, spray pump devices for nasal delivery, and training kits with devices for nasal delivery, sold empty.
- Class 20
- Medicine cabinets.
- Class 35
- Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online pharmacy services.
- Class 44
- Medical and health information services; providing information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips for patients, medical professionals, and pharmacists, via a website; providing pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists, via a website.
PADAGIS US LLC
Representative: Wolff, Bregman and Goller, Technology Park Malha,, Bldg 98, 9695101 Jerusalem, ISRAEL